Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-09-18

Clinical Trial Update: Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing fumaric acid ester-PUVA therapy to acitretin-PUVA therapy for pustular palmoplantar psoriasis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)
  • Fumaric acid esters (fumaric acid ester(s))

Snippet

Sponsor: Medical University of Vienna | Conditions: Pustular Palmoplantar Psoriasis | Phase 3 | Status: UNKNOWN